|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.12 EUR | -1.14% |
|
-6.07% | +35.42% |
| 12/07 | Moody's Upgrades Bayer Outlook With Rating Affirmation on "Positive" Court Decision | MT |
| 10/07 | Bayer in the red despite an improved balance sheet structure thanks to Apollo | DP |
Company Valuation: Bayer AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 46,174 | 47,476 | 33,039 | 18,975 | 36,360 | 49,239 | - | - |
| Change | - | 2.82% | -30.41% | -42.57% | 91.62% | 35.42% | - | - |
| Enterprise Value (EV) 1 | 79,140 | 78,749 | 67,302 | 51,329 | 82,696 | 80,986 | 77,768 | 74,512 |
| Change | - | -0.49% | -14.54% | -23.73% | 61.11% | -2.07% | -3.97% | -4.19% |
| P/E | 46.1x | 11.5x | -11.2x | -7.43x | -10.1x | 21.2x | 15.9x | 13.8x |
| PBR | 1.4x | 1.22x | 1x | 0.59x | 1.4x | 1.75x | 1.59x | 1.45x |
| PEG | - | 0x | 0x | 0.6x | -0.2x | -0x | 0.5x | 0.9x |
| Capitalization / Revenue | 1.05x | 0.94x | 0.69x | 0.41x | 0.8x | 1.08x | 1.06x | 1.02x |
| EV / Revenue | 1.8x | 1.55x | 1.41x | 1.1x | 1.81x | 1.78x | 1.67x | 1.54x |
| EV / EBITDA | 7.08x | 5.83x | 5.75x | 5.07x | 8.55x | 8.43x | 7.61x | 6.78x |
| EV / EBIT | 10.8x | 8.51x | 8.87x | 9.44x | 16.2x | 14x | 11.9x | 10.6x |
| EV / FCF | 31.9x | 19x | 28.4x | 11.2x | 24x | -76.7x | 21.2x | 17.4x |
| FCF Yield | 3.13% | 5.26% | 3.52% | 8.94% | 4.16% | -1.3% | 4.71% | 5.75% |
| Dividend per Share 2 | 2 | 2.4 | 0.11 | 0.11 | 0.11 | 0.2364 | 0.6382 | 1.068 |
| Rate of return | 4.26% | 4.97% | 0.33% | 0.57% | 0.3% | 0.47% | 1.27% | 2.13% |
| EPS 2 | 1.02 | 4.22 | -2.99 | -2.6 | -3.68 | 2.364 | 3.159 | 3.639 |
| Distribution rate | 196% | 56.9% | -3.68% | -4.23% | -2.99% | 10% | 20.2% | 29.3% |
| Net sales 1 | 44,081 | 50,739 | 47,637 | 46,606 | 45,575 | 45,552 | 46,654 | 48,242 |
| EBITDA 1 | 11,179 | 13,513 | 11,706 | 10,123 | 9,669 | 9,607 | 10,213 | 10,992 |
| EBIT 1 | 7,295 | 9,257 | 7,589 | 5,436 | 5,108 | 5,782 | 6,529 | 7,020 |
| Net income 1 | 1,000 | 4,150 | -2,941 | -2,552 | -3,620 | 2,146 | 2,992 | 3,522 |
| Net Debt 1 | 32,966 | 31,273 | 34,263 | 32,354 | 46,336 | 31,747 | 28,529 | 25,273 |
| Reference price 2 | 47.00 | 48.32 | 33.63 | 19.31 | 37.01 | 50.12 | 50.12 | 50.12 |
| Nbr of stocks (in thousands) | 9,82,424 | 9,82,424 | 9,82,424 | 9,82,424 | 9,82,424 | 9,82,424 | - | - |
| Announcement Date | 01/03/22 | 28/02/23 | 05/03/24 | 04/03/25 | 04/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.2x | 1.78x | 8.43x | 0.47% | 5.63TCr | ||
| 34.92x | 12.63x | 25.81x | 0.57% | 1,06000Cr | ||
| 27.42x | 6.3x | 17.1x | 2.08% | 62TCr | ||
| 30.1x | 7.34x | 15.02x | 2.76% | 44TCr | ||
| 17.98x | 4.45x | 11.01x | 2.97% | 33TCr | ||
| 21.52x | 5.52x | 13.36x | 2.86% | 28TCr | ||
| 21.56x | 4.53x | 12.65x | 1.94% | 27TCr | ||
| 14.17x | 5.3x | 10.9x | 3.52% | 22TCr | ||
| 23.78x | 6.31x | 11.12x | 2.78% | 20TCr | ||
| -46.02x | 5.6x | 31.12x | 2.5% | 16TCr | ||
| Average | 16.66x | 5.98x | 15.65x | 2.25% | 36.3TCr | |
| Weighted average by Cap. | 23.83x | 7.75x | 18.01x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BAYN Stock
- Valuation Bayer AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















